Objective: To explore parental experiences of whole exome sequencing (WES) for prenatal diagnosis and ascertain what influenced their decision-making to undergo testing.
most regions that encode proteins to identify single nucleotide variants and small insertions and deletions (indels). 5 As a technique, it has proved useful to the diagnosis of known genetic disease and to the discovery of novel disorder genes 7 and is increasingly being used to diagnose rare Mendelian conditions (when standard tests are uninformative). 8 The use of WES in prenatal diagnosis is potentially advantageous as its accuracy enables personalized care, prospective risk assessment, and preventative fertility treatment, reproductive genetic counseling, and family planning. 9 As such, if a definitive diagnosis is made, this testing may aid understanding of etiology, potential comorbidities, and risk of recurrence. However, NGS, in the prenatal setting, presents potential challenges around the interpretation of results, especially if positive results are not thought to be "causative" or are of unknown significance. The detection of these secondary and/or incidental findings (ICFs) may have significant and morbid emotional effects on the parents and also impact negatively on parental decision making in the prenatal setting.
Several studies involving WES in patients with Mendelian disease
have demonstrated a diagnostic yield in the order of 25%. 10, 11 This indicates that WES is complementary to conventional prenatal diagnostic techniques. 12 Research relating to the use of genetic sequencing for prenatal diagnosis in ongoing pregnancy is limited 4 ; however, the feasibility of WES in prenatal diagnostics has been demonstrated in small case series. 3, 12, 13 Survey data involving 186 expectant parents in the USA demonstrated that 83% thought that prenatal WES should be offered, 14 and research into the views of 15 women with noncontinuing anomalous pregnancies found that they had high hopes and expectations of WES, despite testing enabling a diagnosis in only 1 in 3 (30% of cases). 15 Successful implementation of WES for prenatal diagnosis would require rigorous health economic assessment and would be dependent upon the development of rapid analytical and interpretation pipelines. 12 Sequencing findings would need to be available within a timeframe that would assist parents to make informed decisions relating to the affected pregnancy, and this will only be possible when the knowledge base relating to the genetic causes of prenatal structural anomalies is significantly developed. 12 The challenge of prenatal WES will be the integration of sequencing analysis into prenatal diagnostics as part of a responsible and ethical framework for clinical practice. 2 Currently, the PAGE consortium project funded by the Department of Health/Wellcome Trust is prospectively recruiting parent/fetus trios across the UK to investigate the prenatal use of WES as a diagnostic tool in structurally abnormal fetuses. 16 The study will analyze~1000 trio whole exomes with the aim to elucidate the relative contribution of different forms of genetic variation to prenatal structural anomalies.
As the use of WES increases and transfers from the research setting to routine care, it will be important to ensure a streamlined approach to the integration of genomic analysis to existing prenatal care pathways. This transition will require an understanding of parental acceptability and expectations around sequencing analysis for prenatal diagnosis following discussion with parents who have personal experience of this type of genetic testing in pregnancy. These parents will provide a unique perspective on their experiences as it is important to ensure that this technology is translated into clinical care because parents consider it to be of value. What is already known about this topic?
• Prenatal WES for genetic diagnosis is possible, but little is known regarding parental experiences of prenatal sequencing.
What does this study add?
• Parents require specific information to help them decide whether to undergo WES for prenatal diagnosis.
• Appropriate counseling is essential for informed consent.
• 
| ANALYSIS
Analysis of the interview data followed a standard thematic approach. 19 Transcripts were read by EQJ to enable familiarization. Using an inductive process, 20 the transcripts were then coded for similarities and differences in content to develop a coding frame. Encompassing key themes with underpinning subthemes were produced by combining the identified codes. Two transcripts were independently read by SCH (clinical cofacilitator for aforementioned focus groups and interview design) who similarly used thematic analysis to elicit themes. 19 The coding frame developed by EQJ was shared with SCH and was subsequently modified. The coding frame and agreed themes were shared with SMG (medical sociologist). Two further transcripts were analyzed by SMG by using the established coding frame. Further amendments to the coding frame were not thought necessary because of this analysis. All 3 researchers met to reach a consensus that the themes identified were indeed reflective of the accounts provided. A rapid analysis of the interview transcripts was then undertaken by EQJ to ensure completeness and assess for data saturation. 19 A consensus decision by the 3 researchers was made that data saturation had occurred and that no further interviews were required.
| RESULTS
The participants were diverse regarding age, ethnicity, parity, and gestation and had varying diagnoses of both isolated and multiple fetal structural anomalies (Table 1) . Women were aged between 21 and 38 and identified themselves as Caucasian, Black African, or Asian, with
Caucasian women comprising 75% of the sample. Of the 12 women interviewed, 7 (58%) were multiparous and gestational ages ranged from 12 to 38 weeks. There was an equal split between isolated and multiple structural abnormalities, and the prognosis for fetuses was variable and sometimes uncertain.
Five main themes emerged some with multiple subthemes (Table 2 ).
| Theme 1: Parental experiences of prenatal whole exome sequencing
The parents sometimes struggled to balance the risks of invasive testing against the perceived benefit of receiving a genetic diagnosis, particularly if there was uncertainty relating to the ultrasound features and the prognosis for the baby (this was especially true if there was a previous history of miscarriage and any associated traumatic memories)
"It was more the risk factor because I had a miscarriage last year and it was really horrible so we didn't want to go through that again, especially as I was well over 20 weeks and into my second trimester and the baby was fully formed, so that was quite worrying but it wasn't so much for the results" (Interview 4-Mother)
The parents felt shocked when first told that their baby had a congenital difference, but this initial shock was often replaced with ongoing anxiety. Some said it felt as though a "heavy weight" had been placed upon them and found the experience to be extremely scary. The parents appeared to worry more about the uncertain prognosis for the baby and less about the genetic findings that testing might identify.
Many remembered feeling overwhelmed by the different tests available and felt that their worries and concerns were compounded because they had so much to think about at the time:
"It was scary to be honest with you, all the different tests and constant worry. It was worrying because we didn't know what she (baby) would look like or anything like that" (Interview 2-Father)
Self-blame that they had done something to have caused the fetal anomaly was a common parental concern; thus, a desire for reassurance that this was not the case was reported. All parents described that they trusted their clinicians and valued receiving their clear explanations. The parents described that they were assisted in their decision-making when they felt supported by clinicians and believed that any prenatal testing options discussed by the consultant overseeing their care would be relevant and useful, which reassured them:
"We thought that it would give us some reassurance and help us plan and prepare for the future" (Interview
4-Father)
Some parents described how they tried to remain hopeful for a good pregnancy outcome but also felt that they would love the baby regardless of any disability they may have. Some remembered consciously blocking out their concerns in an attempt to keep positive, believing that searching out more information would only serve to exacerbate their worry. When faced with various options, the parents felt that they could make difficult decisions if they were not pressurized and were given enough time:
"I think we've tried to blank quite a lot of it because we don't want to be negative. When she is here we will cross that path won't we?" ( A need for repetition of complex information was also evident as the parents found it difficult to fully understand everything that they were told at the initial consultation. Discussion and explanation on more than one occasion were found to be helpful, and the parents appreciated receiving clinical details in written format relating to the specific anomalies identified:
"Some things you don't understand, some of the things the doctor says" (Interview 2 -Mother)
"But when they break it down into smaller (pieces), all these big words like, and obviously we don't know what they mean, but they do break it down" (Interview 2-Father)
| Theme 3: Consent and reasons for prenatal whole exome sequencing
Desiring more information and a wish to rule out as much as possible were key motivators for parents to undergo prenatal testing. The parents perceived WES as a more detailed assessment to find out additional genetic causes for the anomalies affecting their baby that are not tested for routinely. They considered more information to be the best thing for parents and the baby, and this was often the main reason for testing:
"It was going to test for more than everything else, and if there was anything rare that it is more likely to pick that up, and he explained that it will take much longer"
(Interview 10-Mother)
The parents were aware that testing involved looking for differences and similarities between their individual DNA and the DNA of their baby. It was understood that the testing would not benefit the current pregnancy (because results would not be reported back within the timeframe of pregnancy) but thought that it may be helpful for the baby when older, or if it could provide information for future pregnancy planning:
"It was to try and work out if there is anything between us (parents) that has caused the anomalies. I do not know whether it searches for one or both or whatever, but just that it is trying to find out if there is anything that is within either of us that has made these things happen in the baby" (Interview 3-Mother)
The parents were sometimes uncertain about what was actually being tested for or ruled out and would have appreciated hearing about some example conditions. Most felt that it was better to know about any genetic causes and hoped that the testing would provide answers that would be reported back to them: showed the extremes of disease and were not always relevant. Some accessed NHS websites and Wikipedia feeling that these were more trustworthy sources. Information leaflets on specific conditions were generally found to be helpful:
"We got advice before we came here as well to steer clear of the internet because obviously you get a lot of misinformation, so I kind of took that to heart as it sounded quite sensible so I have not really been googling" (Interview 1-Father)
Interactive sources of support were reported to be helpful, and the parents valued being able to ask questions directly. One couple described that they would have liked to speak to other parents with similar experiences, suggesting that a workshop where they could find out more information and ask questions could be a forum for this: 
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